Jayakumar Preethi, Laganson Andrea, Deng Meihong
Department of Surgery, The Ohio State University, Columbus, OH, United States.
Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, United States.
Front Pharmacol. 2022 Mar 23;13:866993. doi: 10.3389/fphar.2022.866993. eCollection 2022.
Peritoneal resident macrophages (PRMs) have been a prominent topic in the research field of immunology due to their critical roles in immune surveillance in the peritoneal cavity. PRMs initially develop from embryonic progenitor cells and are replenished by bone marrow origin monocytes during inflammation and aging. Furthermore, PRMs have been shown to crosstalk with other cells in the peritoneal cavity to control the immune response during infection, injury, and tumorigenesis. With the advance in genetic studies, GATA-binding factor 6 (GATA6) has been identified as a lineage determining transcription factor of PRMs controlling the phenotypic and functional features of PRMs. Here, we review recent advances in the developmental origin, the phenotypic identity, and functions of PRMs, emphasizing the role of GATA6 in the pathobiology of PRMs in host defense, tissue repairing, and peritoneal tumorigenesis.
腹膜常驻巨噬细胞(PRMs)因其在腹腔免疫监视中的关键作用,一直是免疫学研究领域的一个重要课题。PRMs最初由胚胎祖细胞发育而来,并在炎症和衰老过程中由骨髓来源的单核细胞补充。此外,PRMs已被证明可与腹腔内的其他细胞相互作用,以控制感染、损伤和肿瘤发生过程中的免疫反应。随着遗传学研究的进展,GATA结合因子6(GATA6)已被确定为PRMs的谱系决定转录因子,可控制PRMs的表型和功能特征。在此,我们综述PRMs在发育起源、表型特征和功能方面的最新进展,强调GATA6在PRMs宿主防御、组织修复和腹膜肿瘤发生病理生物学中的作用。